SCHEMBL9700447

SCHEMBL9700447

Cc1c(Sc2ccccc2)c2cccc3c2n1CC(CN)O3

nearest known ligand 0.34

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 3/20 0.34
AKR1B1 P15121 2/20 0.34
MCL1 Q07820 1/20 0.31
SLC6A2 P23975 4/20 0.31
SLC6A4 P31645 3/20 0.31
SLC6A3 Q01959 1/20 0.31
CYP2D6 P10635 2/20 0.30
CASR P41180 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9699053 0.87 CASR (0.35) PTGDR2AKR1B1SLC6A2SLC6A4SLC6A3
SCHEMBL9701354 0.85 ADRA2A (0.41)
SCHEMBL9701452 0.85 ADRA2A (0.44)
SCHEMBL9699255 0.85 SLC6A4 (0.33) PTGDR2AKR1B1SLC6A4
SCHEMBL9700258 0.84 ADRA2A (0.46)
SCHEMBL9701663 0.83 HRH3 (0.41)
SCHEMBL9700246 0.82 HTR1A (0.34)
SCHEMBL10471317 0.81 HRH3 (0.39)
SCHEMBL9700627 0.79 HRH3 (0.38)
SCHEMBL9700623 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5112820-A Vision defects STERLING DRUG INC. (US) 1992-05-12 US disclosed
US-5109135-A 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine intermediates STERLING DRUG INC. (US) 1992-04-28 US disclosed
US-5066803-A Chemical intermediates for analgesics STERLING DRUG INC. (US) 1991-11-19 US disclosed
WO-1990007505-A1 2- AND 3-AMINOMETHYL-6-ARYLCARBONYL-2,3-DIHYDROPYRROLO[1,2,3-de]-1,4-BENZOXAZINES STERLING DRUG INC. (US) 1990-07-12 WO disclosed
US-4939138-A 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines STERLING DRUG INC. (US) 1990-07-03 US disclosed